Facilitated By

San Antonio Medical Foundation

News

  • Arvinas Announces Data Presentations from the Vepdegestrant Clinical Development ...

    Arvinas, Inc. a clinical-stage biotechnology company creating a ... San Antonio Breast Cancer Symposium taking place December 9–12, 2025 in ...

  • Osisko Development Announces Agreement to Divest Non-Core San Antonio Gold Project

    ... Biotechnology Stocks · Cannabis Stocks · Clean Energy Stocks · Crypto ... (TSXV:AXO) ("Axo") to sell its 100% interest in the San Antonio Gold ...

  • REEP Earns Seventh Consecutive San Antonio Business Journal Fast Track Award

    Biotechnology · Clinical Trials & Medical Discoveries · Dentistry ... San Antonio Business Journal's Fast Track Awards for the seventh year in a row.

  • CytoDyn to Present Leronlimab mTNBC Data at SABCS 2025 | CYDY Stock News

    ... San Antonio Breast Cancer Symposium (SABCS), being held December 9-12 ... Clearside Biomedical to Pursue Strategic Sale of its Business Through ...

  • Bellevue-linked biotech lands licensing deal worth up to $835 million

    San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Swiss biotech Vaximm AG, a subsidiary of Bellevue-based OSR Holdings ...